Session Details

U049 Atopic Dermatitis in Young Children: Controversies, Concerns, and Current Guidelines

Sat, Mar 9, 4:30 PM - 5:30 PM
Room 6A
1 CME Available Focus Session
View Map

DESCRIPTION

Atopic dermatitis is one of the most commonly encountered diagnoses in the treatment of skin disease in children. There are numerous considerations to take into account regarding young children, including the effects of topical and systemic therapies, parental concerns and treatment preferences, and role of allergies in eczema, including the role of the dermatologist in reducing the burden of the atopic march. This session is directed towards all practitioners who see children with atopic dermatitis as part of their practice and will provide various pearls to effectively manage pediatric eczema.

LEARNING OBJECTIVES

1.

Review the literature regarding safety and efficacy of topical and systemic medications for atopic dermatitis in young children.

2.

Evaluate the role of allergies in patients with atopic dermatitis and when to suspect concurrent atopic disorders.

3.

Discuss current controversies in the management of atopic dermatitis, highlighting the current literature.

SCHEDULE

4:30 PM

Atopic Dermatitis in Young Children

DIRECTOR

Karen Chernoff, MD, FAAD

Karen Chernoff, MD, FAAD

SPEAKER

Vikash Sudhir Oza, MD, FAAD

Vikash Sudhir Oza, MD, FAAD

DISCLOSURES

Karen Chernoff, MD, FAAD

No financial relationships exist with ineligible companies.

Vikash Sudhir Oza, MD, FAAD

Apogee BioPharm – Consultant(Honoraria); ASLAN Pharmaceuticals – Advisory Board(Honoraria); CeraVe/Valeante – Advisory Board(Honoraria); Dove/Unilever – Consultant(Fees); La Roche Posay Dermatologique – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); VisualDx – Other(Fees);